3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
24
Breast Neoplasms
15
Sarcoma
9
Myelodysplastic Syndromes
9
Carcinoma, Non-Small-Cell Lung
9
Stomach Neoplasms
8
Multiple Myeloma
7
Leukemia, Myelomonocytic, Chronic
7
Myeloproliferative Disorders
6
Uterine Cervical Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Recurrence
4
Prostatic Neoplasms
4
Neoplasms
4
Melanoma
4
Lung Neoplasms
4
Leukemia, Monocytic, Acute
4
Head and Neck Neoplasms
4
Carcinoma, Hepatocellular
4
Biliary Tract Neoplasms
4
Advanced Solid Tumour
4
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Neuroendocrine Tumors
3
Mucositis
3
Leukemia, Myelomonocytic, Acute
3
Esophageal Squamous Cell Carcinoma
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Interventions
Cyclophosphamide
108
Rituximab
62
Etoposide
56
Methotrexate
52
Cytarabine
52
Peripheral Blood Stem Cell Transplantation
47
Vincristine
45
Filgrastim
43
fludarabine phosphate
41
Radiotherapy
37
Mycophenolic Acid
35
Doxorubicin
35
Tacrolimus
33
Busulfan
33
Whole-Body Irradiation
32
Prednisone
31
Methylprednisolone
27
Antilymphocyte Serum
27
Dexamethasone
26
Cyclosporine
26
Melphalan
24
merphos
20
blinatumomab
20
Leucovorin
20
Granulocyte Colony-Stimulating Factor
16
Carmustine
15
fludarabine
14
Ifosfamide
14
Calcium Dobesilate
14
CT-P10
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Burkitt Lymphoma
×
Injections
×
Clear all
NCT01314014
2016-01-06
ULYM11011
University of Rochester
Phase 2
Completed
22 enrolled
8 charts